Developing a new medical device is rarely a straightforward journey. By some estimates, less than one-third of funded medical device projects ever succeed in reaching a marketable product, and nearly all that do hit at least one major crisis along the way. In the United States, roughly 75% of medical device startups ultimately fail to achieve market success. These sobering figures underscore just how many roadblocks can derail a promising concept. From complex technical hurdles to navigating stringent regulations and an unforgiving marketplace, engineers face a unique set of challenges at every stage of development.
In this article, we explore the most common roadblocks in medical product development, particularly from an engineer’s perspective, and discuss strategies and best practices to avoid or mitigate these issues. By understanding these pitfalls and how to address them, development teams can improve their odds of delivering a safe, effective device that meets both regulatory requirements and market needs. For an in-depth look at the overall development process, see our Medical Product Development Complete Overview.
Technical Obstacles in Product Development
A multidisciplinary engineering team reviews a CAD model of a medical device design. Early-stage prototyping and design iterations help uncover technical issues before they become costly roadblocks.
From an engineering standpoint, technical hurdles are often the most immediate and visible challenges in medical product development. These include design complexities, integration of new technologies, and ensuring the device will work reliably and safely under real-world conditions. Below are some of the most common technical roadblocks and how to address them:
Unclear Requirements and Design Changes
Nothing throws a development project off schedule (and budget) faster than discovering late in the game that a requirement was misunderstood or overlooked. Ill-defined product requirements lead to redesigns, cost overruns, and delays. The best practice is to define clear, comprehensive requirements from the start – including not just core user needs but also often-overlooked criteria like regulatory requirements, data security, interoperability, and even reimbursement considerations.
Make sure to include all stakeholders (engineering, clinical, regulatory, marketing, etc.) early in the requirements definition process. By setting a solid foundation with concise specifications, teams can reduce costly mid-project changes and realize faster time-to-market.
High Development Costs and Project Delays
The time and resources required to take a device from concept to reality are substantial. Engineers frequently face pressure to accelerate development, but rushing can backfire if it leads to design errors. One major cost driver is having to repeat work, for example, rebuilding a prototype because of design flaws or test failures discovered late. To mitigate this, adopt an iterative prototyping and testing approach. Rapid prototyping allows teams to fail fast and cheap, catching design flaws early before they require expensive rework.
According to industry experts, investing in thorough prototyping and early testing minimizes costly “dead-end” designs and supports extensive safety/usability testing before full commitment. In practice, this means building multiple prototype iterations, performing rigorous bench tests and simulations, and refining the design at each step. While iterative development requires upfront effort, it ultimately reduces the risk of major redesigns and keeps the project on schedule.
Integrating New Technologies (Software, IoT) Securely
Modern medical devices increasingly incorporate software, connectivity, and advanced electronics – from wireless IoT features to AI-driven algorithms. These technologies bring tremendous benefits but also introduce new failure modes. In fact, since 2014 software issues have overtaken hardware design issues as the leading cause of FDA medical device recalls.
One analysis identified 627 software-related recalls (affecting 1.4 million device units) in just a five-year span. Cybersecurity is another growing concern as connected devices must protect sensitive patient data. Engineers may find themselves grappling with data encryption, wireless interoperability, and compliance with cybersecurity standards. The key strategy here is “security by design” – i.e. plan and design for software reliability and data security from the outset, rather than treating it as an afterthought. Include IT and software experts on the development team early, and incorporate privacy and security requirements into your product requirements document.
Designing robust software architecture, performing threat modeling, and following medical software lifecycle standards (such as IEC 62304 for software development and FDA cybersecurity guidance) will help prevent technology snares down the line. By addressing technology integration and data integrity issues at the requirements and design phase, companies can avoid many pitfalls that would otherwise surface during verification or, worse, post-market.
Quality and Reliability Issues
Medical devices must meet a high bar for safety and reliability. Poor product quality can lead to serious patient harm, not to mention devastating recalls and liability for the manufacturer. Product recalls remain a significant roadblock that can undo years of development effort. According to a McKinsey analysis, non-routine quality problems (e.g. major FDA observations, warning letters, recalls, and related lawsuits) cost the medical device industry an estimated $2.5–$5 billion per year – including up to $3 billion in direct costs and $2 billion in lost sales. To avoid quality-related catastrophes, teams should build quality by design into every stage of development. In practice, this involves rigorously applying design controls and risk management.
For example, engineers should perform thorough risk analyses (FMEAs etc.) and integrate risk mitigation strategies into the design. All design inputs should be clear, measurable, and tied to verification/validation tests. Incorporating usability engineering early, following standards like IEC 62366-1 for human factors, helps ensure the device is safe and effective in actual user hands. It’s also wise to conduct internal reviews and bench testing beyond the minimum, to catch performance or durability issues. By front-loading quality considerations (and continuing to monitor post-market feedback), engineering teams can significantly reduce the chance of a costly recall or safety failure down the road.
Manufacturing & Scalability Challenges
An often underrated engineering roadblock is designing a device that is easy to manufacture at scale. A prototype that works in the lab may be difficult or expensive to mass-produce reliably. Startups in particular may lack manufacturing expertise in-house, leading to designs that face problems during scaling.
To prevent this, adopt Design for Manufacturability (DFM) and Design for Assembly (DFA) principles from the beginning. Engineers should consider the choice of materials, availability of components, and simplicity of assembly in their design decisions. Engaging with manufacturing specialists or partners early can uncover potential production issues (tolerances, tooling, etc.) before the design is locked in.
Many successful teams use a cross-functional development approach, collaborating closely with mechanical engineers, supply chain experts, and contract manufacturers during development. This ensures the transition from prototype to production is smooth. Likewise, establishing a pilot production or medical device prototyping process can validate that the design can be produced repeatably and scaled up. In short, always keep the endgame in mind: a design isn’t truly complete until it’s manufacturable.
Regulatory and Compliance Challenges for Medical Products
Navigating the regulatory landscape is arguably the single biggest hurdle in medical product development. Engineers, whose expertise is often in technology, may feel overwhelmed by the maze of regulations, standards, and documentation required to get a device approved. Yet ignoring or underestimating regulatory requirements can stop a project in its tracks. Some common regulatory roadblocks include:
Complex Approval Pathways & Evolving Regulations
Medical devices are subject to stringent oversight by agencies like the U.S. FDA and international bodies. Determining the correct regulatory pathway (e.g. FDA class I/II/III, 510(k) vs. PMA, EU MDR classification, etc.) early on is critical. Each pathway comes with specific data requirements, from biocompatibility testing to clinical trial evidence. A major challenge is that regulations are a moving target – they vary by region and are updated periodically.
For instance, the European Union’s transition from the MDD to the newer MDR regulations has introduced tougher requirements and created bottlenecks in approvals. With fewer notified bodies available post-Brexit, EU medical device approvals can now take 12–18 months or more. Keeping pace with such changes is non-trivial. The mitigation strategy here is twofold: educate and plan.
Development teams (not just the regulatory specialists) should have at least a high-level understanding of the relevant standards (ISO 13485 for QMS, ISO 14971 for risk management, etc.) and regulatory expectations.
Understanding the intent behind regulatory requirements (not just the letter of the law) helps engineers anticipate what regulators will be looking for. Early in the project, define a regulatory strategy as part of your design inputs. This means mapping out what approvals are needed, identifying key regulatory risks (e.g., will the device be considered a software-as-medical-device? Does it require a clinical study?), and planning for compliance activities in the project timeline. Engaging a regulatory affairs expert or consultant at the outset can save enormous time and cost later. In short, make regulatory compliance a built-in design requirement, not an afterthought.
Documentation and Quality System Burdens
Bringing a medical device to market requires mountains of documentation – design history files, device master records, risk management files, test reports, clinical evidence, and more. Small companies can be especially challenged by the overhead of implementing a robust Quality Management System (QMS) to ISO 13485 or FDA 21 CFR 820 standards. However, skimping on documentation or quality processes is not an option; it inevitably leads to delays or failures during regulatory review.
A common roadblock is when companies treat regulatory documentation as a separate task at the end, rather than integrating it into development. This often results in last-minute scrambles to assemble paperwork, or missing data that requires repeating tests. To avoid this, adopt a “compliance by design” mentality. Maintain good design control practices throughout (requirements tracing, design reviews, change control, etc., all captured in your records).
Leverage templates and tools to streamline documentation – for example, requirements management software can ensure your design inputs, outputs, verifications and validations are all linked and compliant. It’s also wise to conduct internal audits or peer reviews of the DHF (Design History File) during the project, to catch any gaps well before an external audit or submission. Yes, it’s extra work, but it beats having a 510(k) submission rejected for incompleteness or failing an ISO audit when the stakes are high.
Regulatory Submission Hurdles
Even after engineering and testing a great product, clearing the final regulatory review can be a roadblock. Many firms underestimate the rigor of the submission process. For example, the FDA’s 510(k) pathway (for moderate-risk devices) has some eye-opening statistics: about one-third of 510(k) submissions fail the initial acceptance review because of omissions or administrative errors.
In 2021, roughly 35% of submissions were refused on first pass, often for not having all the required elements. Even among those accepted, about 67% of 510(k) submissions receive an “Additional Information” request from the FDA, which pauses the review clock and extends the timeline. These delays can add months to what is nominally a 90-day review cycle, pushing the actual average FDA decision time closer to 5–6 months. The lesson is clear: meticulous preparation of regulatory submissions is crucial. Companies can avoid many iterations by thoroughly understanding the guidance documents, checklists, and expectations before submitting.
Best practices include conducting a pre-submission meeting with the FDA (to clarify any novel aspects of your device), having a regulatory expert or third party review your submission for completeness, and responding to queries promptly and thoroughly. It’s also important for engineers to design and document with the submission in mind – for instance, if you know you’ll need to demonstrate safety for a particular standard, perform those tests during development rather than after the fact. As Arrotek notes, many submission delays and requests for more data are avoidable with better planning and expertise upfront. In short, invest the time to “get it right the first time” when it comes to regulatory submissions.
Compliance in Production and Post-Market
Regulatory challenges don’t end once the device is approved. Engineers must also design for compliance during manufacturing and the product’s lifecycle. This includes setting up appropriate process controls, incoming inspection for components, and ensuring any changes post-approval are handled under design change control. A potential roadblock is failing to plan for process validation and scale-up – e.g. not validating manufacturing processes (IQ/OQ/PQ) for a class II/III device, which can delay shipments or trigger regulatory action.
Additionally, new regulations like the FDA’s Unique Device Identification (UDI) system or the EU’s post-market surveillance and vigilance reporting requirements impose ongoing obligations. The best practice to handle this is to work closely with quality and manufacturing teams as the design is finalized, to ensure smooth transfer to production under a compliant QMS. Conducting pilot production runs under QA oversight can flush out issues. Also, establishing a robust post-market monitoring plan (for customer feedback, complaints, etc.) will help catch any field issues early and fulfill regulatory reporting duties.
By treating regulatory compliance as a continuous thread – from concept through post-launch, companies can avoid the nightmare of compliance failures after going to market. For example, not fully supporting compliance can lead to test failures, rejected submissions, or costly back-and-forth delays during product launch. DeviceLab’s own Regulatory Compliance approach emphasizes early and ongoing compliance to prevent such issues.
Best Practices to Overcome Development Challenges
Given the wide array of challenges outlined above, how can engineering teams improve their odds of success? Below is a summary of key best practices that help avoid or mitigate common roadblocks in medical product development:
Start with a Strong Plan & Requirements: Invest time in upfront planning. Define comprehensive requirements (user needs, regulatory needs, business needs) and get alignment from all stakeholders. A clear roadmap will guide the team and prevent costly course-corrections later.
Adopt Iterative Design and Prototyping: Use an Agile mindset even for hardware. Iterate early and often: build prototypes, test them, gather user feedback, and refine. This approach catches design and usability issues when they are easier (and cheaper) to fix.
Integrate Regulatory Expertise Throughout: Don’t silo regulatory compliance. Have regulatory and quality experts involved in design meetings from day one. Train engineers on the basics of FDA/EU requirements so they understand the “why” behind certain design inputs. This ensures compliance is baked into the product, reducing last-minute surprises.
- Manage Risk Meticulously: Proactively identify technical and safety risks (using tools like risk assessments, FMEA) and address them in the design. Keep a living risk management file and update it as you test and learn. This not only helps make a safer device but also satisfies regulatory expectations for risk control.
- Ensure Quality via Design Controls: Follow a rigorous design control process: trace requirements to design outputs to verification tests. Perform thorough design reviews at milestones. By enforcing good design practices and documentation, you can spot problems early and have the evidence needed for regulatory submissions.
- Keep the User at the Center: Continually incorporate human factors engineering and user feedback. Conduct formative and summative usability testing as needed. A device that is intuitive and solves the user’s actual pain points will face far fewer market adoption issues.
- Plan for Manufacturing and Scaling: Engage manufacturing engineers or suppliers early to advise on DFM/DFA. Build pilot runs to validate your processes. It’s crucial to confirm that your design can be produced at scale without issues. This forethought will save you from nasty surprises when scaling up production.
- Develop a Go-To-Market Strategy: Even as engineering is underway, devote resources to crafting a market entry and commercialization strategy. Identify early adopter markets, gather clinical evidence for marketing, plan distribution channels, and ensure there’s a reimbursement pathway. This strategic groundwork guides the product development towards meeting real market demands.
- Stay Agile and Adaptive: Finally, remain flexible. Despite best efforts, roadblocks will arise. The teams that succeed are those that can learn and adapt. If a prototype fails, treat it as a learning opportunity and iterate. If regulations shift, pivot your strategy accordingly. By fostering a culture of continuous improvement and problem-solving, engineering teams can navigate even unexpected challenges.
Stuck in Medical Device Development? DeviceLab Can Help You Break Through
Medical product development is undeniably complex – a “tortuous multidisciplinary pathway,” as it’s often described. Engineers must juggle cutting-edge technical work with regulatory compliance and business realities, all under the high stakes of patient safety and significant investment. While the road is challenging, it is navigable with the right approach. By anticipating common roadblocks and addressing them proactively, teams can dramatically improve their chances of success.
At DeviceLab, we have seen first-hand how early planning, cross-functional expertise, and a rigorous development process can turn potential roadblocks into mere speed bumps. We emphasize a structured yet flexible medical device development process that integrates engineering excellence with quality systems and market savvy. The result is a smoother path from idea to FDA-approved, market-ready product. Every hurdle – be it a tricky design requirement, a regulatory question, or a go-to-market decision – is easier to overcome when you have a seasoned team and best practices guiding you.
In the end, developing a successful medical device is about marrying innovation with discipline. By following the strategies outlined above, engineers can avoid the common pitfalls that derail so many projects. With careful planning, user-focused design, regulatory diligence, and a clear market vision, even a small team can bring a life-changing medical product to the finish line. And for those tackling this rewarding journey, remember that you don’t have to go it alone – partnering with experienced development firms (like DeviceLab) or advisors can provide the extra support and insight needed to navigate challenges and ultimately improve patient lives with your new device.
